Upregulation of HER-2/neu by ovarian ablation: results of a randomized trial comparing leuprorelin to CMF as adjuvant therapy in node-positive breast cancer patients.
about
Upregulation of HER-2/neu by ovarian ablation: results of a randomized trial comparing leuprorelin to CMF as adjuvant therapy in node-positive breast cancer patients.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Upregulation of HER-2/neu by o ...... sitive breast cancer patients.
@en
Upregulation of HER-2/neu by o ...... sitive breast cancer patients.
@nl
type
label
Upregulation of HER-2/neu by o ...... sitive breast cancer patients.
@en
Upregulation of HER-2/neu by o ...... sitive breast cancer patients.
@nl
prefLabel
Upregulation of HER-2/neu by o ...... sitive breast cancer patients.
@en
Upregulation of HER-2/neu by o ...... sitive breast cancer patients.
@nl
P2093
P2860
P356
P1476
Upregulation of HER-2/neu by o ...... sitive breast cancer patients.
@en
P2093
K D Wernecke
K Possinger
Takeda Adjuvant Breast Cancer Study with Leuprorelin Study Group
P2860
P2888
P304
P356
10.1023/A:1024911625339
P407
P577
2003-08-01T00:00:00Z
P6179
1004661524